🇺🇸

US SEC Filing Intelligence

· daily

US Executive Officer Management Changes SEC — September 02, 2026

The September 2, 2026, digest of 31 filings reveals a significant wave of leadership transitions across US-listed companies, with a notable concentration of CFO changes (Hershey, NPK International, American Healthcare REIT, Allogene Therapeutics) and CEO departures (Acro Biomedical, Reliability Inc., authID, Definitive Healthcare). While most transitions are described as planned or mutual, several carry heightened materiality due to going-concern qualifications (BioRestorative Therapies, authID), conditional resignations tied to governance disputes (Better Home & Finance), or dramatic stock option repricing reflecting severe share price declines (Cloudastructure). The Lowe's executive appointments stand out as a positive, strategic reorganization to drive growth. Overall, the digest points to a period of corporate restructuring and succession planning, with a few high-risk situations requiring immediate investor attention. No period-over-period financial trends (revenue growth, margin compression) are available as the filings are event-driven 8-Ks without financial statements.

31 high priority 31 total filings
· daily

US Bankruptcy Chapter 11 Insolvency SEC Filings — September 02, 2026

The sole filing in this session involves Twinlab Consolidated Holdings, Inc., which is undergoing an Assignment for the Benefit of Creditors (ABC) proceeding—a common alternative to Chapter 11 bankruptcy. cbdMD, Inc. has entered a definitive asset purchase agreement to acquire Twinlab's operating assets and brands, including Twinlab, Reserveage, Metabolife, and Alvita Tea. The transaction is expected to boost cbdMD's trailing twelve-month revenue to approximately $30 million, a 40% increase over its standalone revenue, though this figure is illustrative and not guaranteed. The deal is subject to court approval, reflecting the insolvency-driven nature of the sale. No period-over-period comparisons, insider activity, or forward-looking guidance were provided in the filing, limiting trend analysis. The mixed sentiment stems from the strategic opportunity for cbdMD versus the underlying distress of Twinlab. This is a quiet session with no other bankruptcy or insolvency filings, making this the sole actionable event.

1 high priority 1 total filings
· daily

US Corporate Board Director Changes SEC Filings — September 02, 2026

The 31 filings reveal a significant wave of leadership transitions across US public companies, with a notable concentration of CFO and C-suite departures in the small-cap and micro-cap space. While the majority of changes are routine retirements or planned transitions, several filings carry heightened materiality due to governance instability, going-concern qualifications, and performance-linked compensation tied to a potential sale. A key theme is the 'revolving door' of interim leadership in cash-constrained companies, with BioRestorative, authID, and Advasa all experiencing simultaneous auditor or CFO changes. Conversely, large-cap firms like Lowe's and Hershey are executing strategic executive appointments to drive growth, signaling confidence in their forward strategies. The data also reveals a pattern of board refreshment, with Vail Resorts and AIG proactively managing board composition, while others like Better Home & Finance face conditional resignations that signal internal conflict. Overall, the digest points to a bifurcated market where established companies are strengthening their benches, while distressed entities are scrambling for stability.

31 high priority 31 total filings
· daily

USA Insider Trading Pulse — September 02, 2026

Today's insider trading pulse reveals a stark divergence: a massive $40M insider purchase by a 10% owner in AMG Pantheon Infrastructure Fund signals strong conviction in infrastructure assets, while multiple C-suite sales under 10b5-1 plans at Sea Ltd, Deere & Co, and Verizon suggest pre-planned but still notable profit-taking. The overwhelming theme is equity awards at Taiwan Semiconductor Manufacturing Co (TSMC), where 19 executives—including the Chairman/CEO—received shares totaling ~500K+ units, reinforcing a long-term alignment culture. On the sell side, a Deere & Co president cashed out ~$1.9M, and a Watts Water director sold $518K, both material. On the buy side, RGC Resources and Granite Ridge Resources saw director purchases at modest levels, signaling local confidence. Period-over-period trends are limited in this batch, but the absence of forward-looking guidance changes across filings is notable—most activity is transactional, not directional. The key takeaway: infrastructure and energy attract insider capital, while tech and industrials see planned liquidation.

50 high priority 50 total filings
· daily

US Merger & Acquisition SEC Filings — September 02, 2026

The US M&A landscape on September 2, 2026, is characterized by a surge in SPAC activity, with three new IPOs (Inflection Point, Southern Cross, JATT III) raising over $395M, alongside a notable de-SPAC completion (D. Boral ARC/Exascale) marred by massive redemptions (96% of public shares). Deal execution risk is elevated, evidenced by one merger termination (Quantumsphere), multiple deadline extensions (Lakeshore, Blue Acquisition), and a delisting notice (Eureka). Strategic divestitures are trending, with INNOVATE and FiscalNote shedding assets to focus on core operations, while G-III's Marc Jacobs acquisition highlights a pivot to owned brands amid a 10% sales decline. Negative signals dominate: SPAC warrant delisting risk (ARC Group), a foreclosure (Chase General), and high redemptions in completed deals. However, opportunities exist in G-III's margin expansion (440 bps) and ROC's strategic acquisition, while the settlement in EGH's litigation removes a key hurdle. Overall, the market shows a bifurcation between well-capitalized strategic buyers and struggling SPACs facing regulatory and shareholder pressure.

17 high priority 17 total filings
· monthly

US Pre-Market SEC Filings Roundup — September 02, 2026

Overnight filings reveal a market bifurcated between aggressive insider buying at micro-cap biotech Quoin Pharmaceuticals and significant insider selling at high-growth industrials like Coherent and Standex, signaling divergent management conviction. The most material corporate event is the termination of the Quantumsphere Acquisition Corp. SPAC merger, a high-risk signal for the de-SPAC market. A notable sector theme is the concentrated insider buying in the biotech/pharma space, particularly at Quoin and Waste Energy, contrasting with routine insider selling for tax purposes at larger caps. Capital allocation is mixed, with Vertiv declaring a modest dividend while VolitionRx continues dilutive convertible note conversions. The Skyworks-Qorvo merger extension provides a key catalyst to monitor, while the HDFC Bank and ICICI Bank credit rating updates offer a positive signal for Indian financials. Overall, the data suggests a cautious market with selective, high-conviction bets in small-cap value and biotech, while large-cap tech and industrial insiders are reducing exposure.

34 high priority 16 medium 50 total filings
· daily

S&P 500 Technology Sector SEC Filings — September 01, 2026

The 14 filings from the S&P 500 Technology sector reveal a mixed picture: while Palo Alto Networks posted explosive 34% YoY revenue growth and a 63% surge in Next-Generation Security ARR, its GAAP net loss of $282M versus a prior-year profit signals heavy investment costs. Microsoft's top executives, including CEO Satya Nadella, engaged in routine tax-withholding stock transactions totaling over $68M, indicating no directional insider selling. Apple's new CEO compensation structure, with a $55M equity target for Ternus, underscores a leadership transition and a focus on long-term performance. Insider selling at ServiceNow and Lam Research, though small in scale, adds a cautious tone. The dominant theme is heavy capital allocation toward AI and security platforms, with Palo Alto's Console acquisition and Microsoft's large equity awards reinforcing this trend. Period-over-period data shows revenue acceleration at Palo Alto but margin compression, while insider activity at Microsoft is neutral and routine. The most critical development is Palo Alto's guidance for FY27 revenue of $14.1B-$14.2B (23-24% growth), which, combined with its NGS ARR trajectory, positions it as a key AI security beneficiary. Overall, the sector is bifurcated between high-growth AI leaders and mature players with stable insider patterns.

5 high priority 9 medium 14 total filings
· daily

Nasdaq 100 Stocks SEC Filings — September 01, 2026

This digest of 12 pre-analyzed NASDAQ-100 filings reveals a dominant theme of insider activity, particularly at Microsoft, where a wave of stock vesting and tax withholding transactions by top executives—including CEO Satya Nadella, CFO Amy Hood, and President Brad Smith—signals routine compensation events rather than directional trading, but underscores the magnitude of equity-linked wealth tied to the company's stock price. Apple's leadership transition filings formalize a massive $100M total equity award target for incoming CEO John Ternus in fiscal 2027, a bullish signal for management continuity and alignment with shareholder value. The two notable open-market insider sales at Lam Research and Booking Holdings, though moderate in materiality, add a cautious tint to those names. Strategy Inc's routine preferred dividend declaration, with a high 12% yield, highlights a capital allocation focus on aggressive leverage and bitcoin exposure. Across the period, no negative revenue or margin trends were reported, but the absence of forward-looking guidance changes and heavy algorithm-driven sales suggests limited near-term tactical signals beyond these compensation and routine events.

3 high priority 9 medium 12 total filings
· daily

US Activist Hedge Fund Institutional SEC 13D 13G — September 01, 2026

The September 1, 2026 batch of 23 filings reveals a dominant theme of passive institutional positioning, with the most significant activist event being a decisive legal victory for ATG Capital against Empery Digital Inc., creating a high-conviction catalyst. A notable cluster of seven separate filings for Universe Pharmaceuticals INC reveals a fragmented ownership structure with multiple 9-10% passive holders, suggesting a potential hidden control structure or coordinated accumulation that warrants close monitoring. The OrthoPediatrics Corp filing shows a major activist (Squadron Capital) actively reducing its 25% stake to raise capital, creating a persistent overhang. Insider activity is minimal across the batch, with the most material signal being the complete exit of Advent International from NCS Multistage Holdings. The period-over-period data is limited in these initial ownership filings, but the transaction details and forward-looking legal catalysts provide actionable intelligence. The overall sentiment is neutral with one high-conviction mixed (bullish) signal from the Empery Digital court ruling. The key takeaway is that while most filings are passive, the Empery Digital situation and the Universe Pharmaceuticals ownership puzzle offer the most alpha generation potential.

4 high priority 19 medium 23 total filings
· daily

S&P 500 Financials Sector SEC Filings — September 01, 2026

The 21 filings in the S&P 500 Financials stream center on a massive, coordinated transfer of CMBS special servicing rights from Greystone Servicing Company LLC to C-IV Asset Management LLC (C-IV AM), effective September 1, 2026, across 13 separate 8-K filings. This bulk transfer, involving roughly 60 securitization transactions and a $20.7 billion portfolio, is a routine administrative change with no material financial impact on any individual trust, but it highlights a key operational trend: the active special servicing portfolio has surged from $969 million (Dec 2023) to $2.1 billion (mid-2026), signaling rising distress in commercial real estate debt, especially office and retail collateral. Separately, insider selling by senior executives at Mastercard, Goldman Sachs, and Visa, along with a 10% owner at Aflac, all under Rule 10b5-1 plans, collectively shows a pattern of monetization but not alarm, though the dollar amounts ($548K–$1.51M) are moderate relative to total holdings. Capital One's routine preferred stock redemption is a minor capital structure cleanup. Period-over-period comparisons from the CMBS data show a 31% decline in the named portfolio from $30.0B (year-end 2024) to $20.7B (mid-2026), potentially due to loan payoffs, while active distressed assets more than doubled, a key divergence. Overall, the digest reveals a sector-wide administrative shakeup in CMBS servicing, a modest wave of insider selling across financial giants, and a growing distress signal in commercial real estate that warrants close monitoring.

5 high priority 16 medium 21 total filings
· daily

S&P 500 Energy Sector SEC Filings — September 01, 2026

This batch of 6 filings from the S&P 500 Energy sector reveals a pronounced bearish insider sentiment among senior executives at major oilfield service and refining companies, with three separate six-figure stock sales by top officers at SLB, Halliburton, and Marathon Petroleum. These disposals, totaling over $3.4 million, are partially executed under Rule 10b5-1 plans, which may indicate pre-planned diversification but still signal a lack of bullish conviction at current valuation levels. In contrast, director-level phantom stock acquisitions at Chevron and a token purchase by a 10% owner at Texas Pacific Land Corp provide a minor counterpoint, suggesting some long-term confidence from non-operational insiders. The period-over-period data from prior filings (not included in this batch) would be essential to contextualize these insider moves against earnings trends, but the concentrated selling by key C-suite officers in the services and refining subsectors is a clear red flag. The overall sentiment is mixed, with a bearish tilt from operational leadership, while capital allocation signals remain absent from these filings, limiting the ability to assess shareholder return trends. The most actionable insight is the divergence between insider selling at SLB and Halliburton versus insider buying at Chevron, which may reflect differing outlooks on the oil price cycle and company-specific strategies.

6 high priority 6 total filings
· daily

S&P 500 Industrials Sector SEC Filings — September 01, 2026

The five filings reveal a mixed picture for the S&P 500 Industrials stream. Caterpillar's financing activities dominate, with two new 364-day credit facilities (one $1.7B) that signal proactive liquidity management and financial flexibility, though they carry no direct performance metrics. Insider activity is a key theme: Caterpillar's CEO exercised options and sold a small portion of shares, while a 10% owner of Republic Services made a significant $34.5M purchase, indicating contrasting management/owner conviction. Boeing's insider transaction is minimal and likely routine. No period-over-period financial trends or forward-looking guidance were provided in these filings, limiting trend analysis. The most actionable signals come from the insider transactions, particularly the Republic Services buy and the Caterpillar CEO's exercise-and-sell pattern. Overall, the stream shows a stable, credit-healthy industrial sector with selective insider confidence.

5 high priority 5 total filings
· daily

US Material Events SEC 8-K Filings — September 01, 2026

This Material Events Monitor digest covers 50 SEC filings from September 1, 2026, revealing a market landscape dominated by major capital allocation events, strategic divestitures, and significant financing activities. Key period-over-period trends include strong revenue growth in the energy services sector (Hornbeck Offshore +12.3% YoY) and digital infrastructure (GitLab +21% YoY), contrasted with margin compression at GitLab (GAAP operating margin worsened to -20% from -8% YoY) and mixed signals from the hospitality sector following Ryman's $1.38B acquisition. The most critical developments include Yum! Brands' $2.7B Pizza Hut divestiture, Red Robin's $96M refranchising, and Moderna's $2.0B convertible note offering, signaling a broad corporate focus on portfolio optimization and balance sheet restructuring. A notable pattern is the surge in debt financing across sectors—from Caterpillar's $1.7B facility to TPG's $1.5B credit line—suggesting companies are locking in favorable terms ahead of potential rate changes. Insider activity is limited but includes voluntary RSU cancellations at Exodus Movement to support strategic integration, while forward-looking guidance from Ryman and GitLab provides key catalysts for Q3 2026.

50 high priority 50 total filings
· daily

Insider Trading Pulse — September 01, 2026

Today's insider trading digest reveals a bifurcated market: aggressive insider selling at NCS Multistage Holdings (9 directors/officers disposing shares in a coordinated event) and Encompass Health (two officers selling ~$1.2M combined) contrasts with notable insider buying at CuriosityStream (CEO bought $52K) and a massive $23M purchase by a 10% owner in John Hancock GA Senior Loan Trust. The most significant capital allocation event is uCloudlink Group's broad-based equity award program, granting 2.65M shares to executives and directors, signaling a major retention and incentive push. Period-over-period analysis of the filings shows no revenue or margin trends as these are transactional filings, but the concentration of insider selling at NCS Multistage (102,531 shares disposed by directors) and the large buy at John Hancock ($23M) are the standout actionable signals. Overall, the digest points to caution in small-cap industrials (NCS) and healthcare (Encompass), while fixed-income and streaming media show insider conviction.

50 high priority 50 total filings
· daily

Dow Jones 30 Stocks SEC Filings — September 01, 2026

This digest of 17 SEC filings from Dow 30 constituents reveals a period of significant insider equity activity, particularly at Microsoft, where a broad-based stock award cycle led to substantial tax-withholding sales across the C-suite. While these transactions are largely programmatic, the sheer volume—totaling over $68 million in stock withheld for taxes—creates a notable overhang. The most actionable signal is the insider sale by Caterpillar's CEO, who exercised and sold shares near the market price, a pattern that warrants monitoring given the company's capital-intensive business cycle. Apple's filing formalizes the new leadership compensation structure for incoming CEO John Ternus and Executive Chair Tim Cook, with a heavy emphasis on performance-based equity, signaling a focus on long-term value creation. Capital allocation activity was minimal, with no dividends or buybacks reported, and no forward-looking guidance was issued. The overall theme is one of routine corporate governance and insider transactions, with the Caterpillar CEO activity being the primary outlier for active investors to assess.

9 high priority 8 medium 17 total filings
· daily

US Corporate Distress Financial Stress SEC Filings — September 01, 2026

The digest reveals a sharp and concentrated wave of distress across eight US-listed companies, centred overwhelmingly on Nasdaq listing deficiencies and acute solvency risks. The dominant theme is a cascade of late-filing violations, with four separate companies (XTI Aerospace, Borealis Foods, CID Holdco, Heritage Distilling) receiving delinquency notices for missing their Q2 2026 10-Q deadlines, pointing to systemic accounting or disclosure issues. The most severe event is BioXcel Therapeutics entering Chapter 11 bankruptcy, a binary outcome that underscores the ultimate crystallization of distress. Insider activity is notably absent across all filings, weakening management's credibility as a signalling tool. Period-over-period comparisons were sparse in these event-driven disclosures, but the sheer density of going-concern warnings (XTI Aerospace) and compound listing failures (authID, CID Holdco) signals that a subset of micro-cap names is facing a liquidity and governance crunch. The critical market implication is that the delisting risk is not isolated; each new deficiency creates a compounding risk that can accelerate the timeline to bankruptcy or forced M&A, as seen in BioXcel's case.

8 high priority 8 total filings
· daily

Global High-Priority Regulatory Events — September 01, 2026

This digest covers 50 filings from September 1, 2026, dominated by a wave of corporate distress and restructuring. The most critical theme is a cluster of bankruptcy, delisting, and going-concern warnings, headlined by **BioXcel Therapeutics** (Chapter 11, 10/10 materiality) and **NCS Multistage** (delisted, 10/10 materiality). A significant M&A cycle is underway, with **Korn Ferry** completing a ~£800M acquisition of AMS and **Helix Energy** filing financials for a potential Hornbeck Offshore acquisition, signaling sector consolidation. The SPAC space shows stress, with **Andretti Acquisition Corp. II** issuing non-redemption agreements to secure its extension vote. A notable hostile bid emerged for **Yatra Online**, which the Board unanimously rejected as undervaluing the company. Across the portfolio, negative sentiment dominates (bankruptcies, delistings, CIRPs), but selective positive signals exist in strategic acquisitions by **ITC Hotels** and **Nephrocare**. The data reveals a bifurcated market: distressed entities are liquidating or restructuring, while well-capitalized firms are deploying capital for growth.

50 high priority 50 total filings
· daily

US SEC Filings Daily Market Digest — September 01, 2026

Today's digest reveals a market bifurcated between aggressive capital returns and significant operational stress. A clear theme is the acceleration of share buybacks, with major players like Equinor, Mizuho, News Corp, and Luckin Coffee all actively returning capital, signaling management confidence. However, this is contrasted by a wave of distress signals, including a Nasdaq deficiency notice for XTI Aerospace, a going-private transaction for Distribution Solutions Group, and a sharp drop in net income for Regis Corp due to a prior-year tax benefit. The SPAC space shows continued activity, with Bleichroeder Acquisition Corp. III taking Ursa Major public and Andretti Acquisition Corp. II scrambling to secure non-redemption agreements to extend its timeline. Insider activity is mixed: a CEO purchase at 17 Education & Technology Group is a positive signal, while a CEO sale at Sea Ltd and a 10% owner sale at Anteris Technologies suggest caution. M&A is picking up, notably Enovis's acquisition of eCential Robotics and TotalEnergies' strategic reshuffling of its renewables portfolio. Overall, the market is rewarding disciplined capital allocation and penalizing operational missteps, with a heightened focus on liquidity and going-concern risks.

22 high priority 28 medium 50 total filings
· daily

S&P 500 Consumer Discretionary Sector SEC Filings — September 01, 2026

The 7 filings from the S&P 500 Consumer Discretionary sector reveal a sector in transition, marked by significant strategic divestitures, strong earnings growth at select retailers, and notable insider selling. Yum! Brands' $2.7 billion total divestiture of Pizza Hut signals a major strategic pivot to focus on KFC, Taco Bell, and Habit Burger, while Ross Stores posted exceptional Q2 FY2026 results with net earnings up 67.6% YoY, showcasing the strength of off-price retail. However, insider selling at Yum! Brands (CEO and KFC Division CEO) and Booking Holdings (CHRO) under 10b5-1 plans, along with a director sale at O'Reilly Automotive, introduces caution. AutoZone's $5M stock award to an SVP Commercial indicates retention and confidence in commercial growth. The sector shows a bifurcation between companies executing successful turnarounds (Ross Stores) and those undergoing strategic restructuring (Yum!), with insider activity suggesting mixed management sentiment. Period-over-period data highlights Ross Stores' margin expansion and inventory build, while Yum!'s divestiture creates both near-term cash and execution risk.

7 high priority 7 total filings
· daily

S&P 500 Healthcare Sector SEC Filings — September 01, 2026

The S&P 500 Healthcare digest for September 1, 2026, reveals a sector bifurcated between strong operational execution and cautious capital management. Medtronic's standout Q1 FY27 results, with 13.7% organic revenue growth and a 40.7% GAAP EPS surge, signal robust demand across its cardiovascular and diabetes portfolios, though the extra fiscal week contributed ~$570M, warranting a normalized growth assessment. In contrast, Moderna's $2.0B zero-coupon convertible note offering highlights a defensive capital raise to fund oncology growth and manage dilution, reflecting a neutral-to-cautious outlook in biotech. Humana's reaffirmed FY26 guidance provides stability but lacks catalysts until CMS releases 2027 Medicare Advantage Star Ratings in October. Insider activity at Thermo Fisher shows a notable divergence: the President & COO sold $2.29M under a 10b5-1 plan, while other executives engaged in routine tax-withholding transactions, suggesting no broad insider concern. Vertex's CFO transition is a low-materiality governance change. Period-over-period trends are limited to Medtronic's strong comparisons, but the lack of negative guidance changes across filings supports a stable sector outlook. The key themes are operational resilience in medtech, cautious capital allocation in biotech, and a wait-and-see approach in managed care, with insider activity providing mixed signals.

10 high priority 2 medium 12 total filings